Table 1 Clinical characteristics of the subjects enrolled in the study.

From: A deleterious role for Th9/IL-9 in hepatic fibrogenesis

Group HC CHB HBV-LC
Subjects 20 30 40
Male 12 18 30
Female 8 12 10
Age(years) 35.5(24–45) 34(18–71) 48.5(27–71)
ALT(U/L) 23.5(10–39) 286(55–889) 27.5(11–124)
AST(U/L) 24.5(12–36) 166(25–1138) 38.5(14–250)
TBIL(μmol/L) 8.45(3.8–16.3) 28.95(6.0–400.1) 22.65(6.7–468.8)
Child-Pugh(A/B/C) ND ND 14/15/7
HBeAg positive 0 20 18
HBV-DNA(copies/ml)
1 × 103−1 × 105 copies/ml 0 8 31
>1 × 105 copies/ml 0 12 9
  1. Data are shown as median and range. HC, healthy control; CHB, chronic hepatitis B patients; HBV-LC, HBV associated liver cirrhosis patients. ND, not determined.